Savient pharmaceuticals - PDFSEARCH.IO - Document Search Engine

Savient pharmaceuticals
Results: 28

#	Item
1	Microsoft Word - Savient Phase 3 Dosing press releasedoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 16:59:22 Medicine Biotechnology PEGylation Pharmacokinetics Pegloticase Savient pharmaceuticals Biology Health Urate oxidase Gout Uric acid Pharmaceutical industry in China
2	Microsoft Word - Savient press release re ACRdoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 17:00:28 Medicine Health care Health Rheumatology Inborn errors of purine-pyrimidine metabolism Uric acid Pegloticase Savient pharmaceuticals Gout Tophus Hyperuricemia Clinical trial
3	Microsoft Word - Savient press release Puricase SPAdoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 17:00:21 Medical research Pharmacology Health Food and Drug Administration Pharmaceutical industry Clinical research Drug discovery PEGylation Pharmacokinetics Savient pharmaceuticals Pegloticase FDA Special Protocol Assessment
4	Microsoft Word - puricase-Phase I-ivpress release.doc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 17:00:34 Medicine Clinical medicine Inborn errors of purine-pyrimidine metabolism Uric acid Chemistry Pegloticase Gout Hyperuricemia Savient pharmaceuticals Urate oxidase Allopurinol Allantoin
5	Microsoft Word - Savient Reports Positive Top-Line Resultsdoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 16:59:55 Medicine Health Medical research Pegloticase Savient pharmaceuticals PEGylation Gout Uric acid Clinical trial
6	Microsoft Word - Savient Resubmits Biologics License Application for KRYSTEXXAdoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 16:59:56 Biotechnology Pharmacology Biology Pharmaceutical sciences Savient pharmaceuticals Pegloticase Food and Drug Administration PEGylation Forward-looking statement Biopharmaceutical Biologic license application
7	Microsoft Word - Puricase P3 enrollment completed press releasedoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 16:56:30 Medical research Pharmacology Pharmaceutical sciences Savient pharmaceuticals Pharmaceutical industry Clinical research PEGylation Pegloticase Clinical trial Forward-looking statement
8	Microsoft Word - Savient Announces FDA Advisory Paneldoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 16:59:17 Savient pharmaceuticals Food and Drug Administration Pegloticase Health FDA Special Protocol Assessment Priority review Forward-looking statement Oxandrolone
9	Microsoft Word - Savient press release on ACRdoc Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 17:00:27 Medicine Health Rheumatology Inborn errors of purine-pyrimidine metabolism Uric acid Clinical research Pegloticase Savient pharmaceuticals Gout Hyperuricemia Tophus Placebo
10	Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies Add to Reading List Source URL: www.mvpharm.com Language: English - Date: 2016-07-11 17:03:22 Medicine Clinical medicine Health Rheumatology Inborn errors of purine-pyrimidine metabolism Uric acid Pegloticase Savient pharmaceuticals PEGylation Tophus Gout Allopurinol